NEWS
Findings may lead to new personalized prevention and early detection strategies
Targeting retrotransposons is an unexplored option for people Down syndrome that this work demonstrates is of great therapeutic interest.
The #GenigmaChallenge concludes with more than 39,000 people participating from 154 countries
Genomic and proteomic analysis reveals that the regulatory role of chromatin is a eukaryotic innovation
A new Proof of Concept Grant will aid the exploration of new methods that improve the therapeutic effectiveness of cytokines
The findings could pave the way for generating artificial oocytes in the laboratory
Research means that in the future a saliva test could be as informative and routinely used as blood tests
The deadline for applications is the 28th of August at 5PM Central European Summer Time.
New tool provides a second chance for patients who have exhausted the routine clinical pathway
News piece published by EU-LIFE on 2nd May 2022